Results 211 to 220 of about 35,539 (289)
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study. [PDF]
J Pediatric Infect Dis Soc, 2020 Klein NP, Abu-Elyazeed R, Povey M, Macias Parra M, Diez-Domingo J, Ahonen A, Korhonen T, Tinoco JC, Weiner L, Marshall GS, Silas PE, Sarpong KO, Ramsey KP, Fling JA, Speicher D, Campos M, Munjal I, Peltier C, Vesikari T, Baccarini C, Caplanusi A, Gillard P, Carryn S, Henry O. +23 moreeuropepmc +1 more sourceConcomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in Taiwan
, 2014 Li‐Min Huang, Tzou‐Yien Lin, Cheng‐Hsun Chiu, Nan-Chang Chiu, Po-Yen Chen, Shu-Jen Yeh, Mark Boaz, Yanee Hutagalung, Alain Bouckenooghe, Emmanuel Feroldi +9 moreopenalex +1 more sourcePrenatal Exposure to Poly- and Perfluoroalkyl Substances (2009–2014) and Vaccine Antibody Titers of Measles, Mumps, Rubella, and Varicella in Children Four to Eight Years Old from the Healthy Start Cohort
, 2023 L. Zell-Baran, Dana Dabelea, Jill M. Norris, Deborah H. Glueck, John L. Adgate, Jared M. Brown, Kylie K. Harrall, Antonia M. Calafat, Anne P. Starling +8 moreopenalex +1 more sourceThe immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy
, 2016 Paolo Durando, Susanna Esposito, Gianni Bona, Mario Cuccia, Maria Giuseppina Desole, Giuseppe Ferrera, Giovanni Gabutti, Angelo Pellegrino, Filippo Salvini, Ouzama Henry, Michael Povey, Federico Marchetti +11 moreopenalex +1 more source